INTRODUCTION
Despite state-of-the-art treatment strategies, advanced antibiotic development, and optimal health care, acute sepsis syndrome (SS) remains a global threat and the leading cause of death in hospitalized patients [1] [2] [3] [4] . Sepsis is also associated with elevated in-hospital mortality in the elderly, ranging from 30% to 60% [5] [6] [7] . Death from SS is caused by a complicated process that involves myriad factors [8] [9] [10] . Of these factors, overwhelming immune response (i.e., host response), generations of oxidative stress and reactive oxygen species (ROS), and overcompensatory inflammatory reaction [4, 8, 9] are the major contributors to direct or indirect assaults to the vital organs [11] [12] [13] [14] . Additionally, studies have shown that SS-related organ damage, especially in the settings of acute lung injury and acute kidney injury commonly encountered in critically ill patients [13] , were strongly associated with untoward prognostic outcomes [9] [10] [11] [12] [13] [14] [15] [16] [17] . Although use of antibiotics is the gold standard treatment of SS [1, 2] , the in-hospital mortality rate of SS is still unacceptably high. This could be mainly due to the fact that antibiotics cannot effectively control the overwhelming immune response and vigorous inflammatory reaction. Therefore, in addition to the appropriate choice of antibiotics [1, 2] , control of the overwhelming immune response and vigorous inflammatory reaction that contribute to damage of vital and vulnerable organs may be crucial to reduce sepsis-induced morbidity and mortality [8] [9] [10] .
Not only has growing evidence demonstrated that stem cells, especially adipose-derived mesenchymal stem cells (ADMSCs), possess the intrinsic capacity of immunomodulation [18, 19] , but stem cell therapy has also been shown to attenuate inflammation and immune responses [18] [19] [20] . Of particular interest, limited experimental studies suggest that, in the setting of sepsis syndrome, stem cell treatment could reduce mortality through clearance of bacteria, regulation of overwhelming immune response, and alleviation of sepsis-induced inflammatory reactions and the generation of oxidative stress/reactive oxygen species [21] [22] [23] .
However, data on stem cell treatment of SS remain too limited to allow adequate evaluation of its therapeutic potential. Moreover, in the setting of SS, the effect of stem cells compared with that of antibiotics, as well as that when the two are combined, remains unclear. Accordingly, this study tested the hypothesis that ADMSC-supported ciprofloxacin would be superior to ciprofloxacin monotherapy in reducing bacterial sepsis-induced urogenital organ damage and mortality. 
MATERIALS AND METHODS

Ethics
Estimation of Sample Size for Different Groups
On the basis of our previous work [25] , it was estimated that mortality in rats at 72 hours after SS induction without treatment would be about 40%-50%. In addition, we calculated that at least eight surviving rats would be required in any one group for statistical significance to be reached at day 5 after sepsis induction. Accordingly, 16 rats were randomly assigned to each group. Survival of the animals was recorded.
Animal Grouping, Sepsis Syndrome Induction, and Rationale of Regimen of ADMSC and Ciprofloxacin Pathogen-free, adult male Sprague-Dawley (SD) rats weighing 350-375 g (Charles River Technology, BioLASCO, Taiwan, http://www.biolasco.com.tw) were randomly assigned and equally divided into group 1 (sham control, intrapelvic injection The dosage of 5.0 3 10 5 intravenously at 30 minutes, 6 hours, and 18 hours after SS induction procedure was based on our previous report [25] , with great modification because we found that the high dose of ADMSC administration to the animals in the previous study (i.e., 1.2 3 10 6 intravenously at 30 minutes, 6 hours, and 18 hours after sepsis syndrome) might induce adverse effects, including a higher mortality rate.
The animals were sacrificed at day 5 after SS induction. The blood sample was collected for measuring the creatinine level at day 5 before the animals were sacrificed. The kidney and urinary bladder tissue specimens were collected for individual study.
In the present study, SS induction mimicked the clinical phenomenon of sepsis from a perforated alimentary tract. Additionally, the time course of ADMSC therapy mimicked the clinical schedule of antibiotic treatment for patients with sepsis syndrome (i.e., every 8 hours) and was based on our recent report with minimal modifications [26, 27] . Furthermore, to elucidate the optimal effect and safety of ciprofloxacin treatment, different regimens of ciprofloxacin (i.e., 1 mg/kg per day [lowest dose], 3 mg/kg per day [intermediate dose], and 6 mg/kg per day [highest dose]) were given to six additional SD rats (one regimen for two animals). Seventy-two hours after SS induction, blood samples were drawn for white blood cell count and differential count. The results showed that the white blood cell count was notably higher in animals receiving the lowest dose than in those receiving the intermediate and highest doses, without significant difference between the latter two groups (12,000 vs. 8,800 vs. 8,600 cells per microliter, respectively). Of importance is that no adverse effect or unstable condition was observed in animals receiving intermediate dose. Therefore, ciprofloxacin, 3.0 mg/kg per day, was used in the present study.
Preparation of Abdominal-Derived Bacteria Using CLP
Five additional SD rats were anesthetized with inhalational 2.0% isoflurane and placed in a supine position on a warming pad at 37°C with the abdomen shaved. Under sterile conditions, the abdominal skin and muscle were opened and the cecum exposed. In the experimental CLP animals, the cecum was ligated by polypropylene sutures over its distal portion (i.e., distal ligation) and the cecum distal to the ligature was punctured twice with an 18-gauge needle to allow the cecal contents to be expressed intraperitoneally, as previously described [25, 26] . The abdominal wound is closed and the animal was allowed to recover from anesthesia. Thirty-six hours after the CLP procedure, the abdomens of the five animals were opened again and the ascitic fluid, which contained colon-derived bacteria (mixed bacteria), was collected and pooled for IPI in the experimental groups (except for the sham controls). The ascitic fluid was collected for quantitative analysis of the amount of bacteria using counting bacteria colony on highpower field (HPF) and Gram stain.
Isolation of Adipose-Derived Mesenchymal Stem Cells
At day 14 before SS induction, isolation of adipose tissue for culturing the ADMSC was performed in groups 3 and 5 (n = 16 for each group). Adipose tissue surrounding the epididymis was carefully dissected, excised, and prepared on the basis of our recent reports [25] [26] [27] [28] . Then, 200-300 ml of sterile saline was added to every 0.5 g of adipose tissue to prevent dehydration. The tissue was cut into ,1-mm 3 pieces using a pair of sharp, sterile surgical scissors. Sterile saline (37°C) was added to the homogenized adipose tissue in a ratio of 3:1 (saline:adipose tissue), followed by the addition of stock collagenase solution to a final concentration of 0.5 units/ml. The centrifuge tubes, with the contents, were placed and secured on a Thermaline shaker (Thermaline, Auburn, Sung, Chiang, Chen et al. WA , https://www.thermaline.com) and incubated with constant agitation for 60 6 15 minutes at 37°C. After 40 minutes of incubation, the content was triturated with a 25-ml pipette for 2-3 minutes.
The cells obtained were placed back on the rocker for incubation. The contents of the flask were transferred to 50-ml tubes after digestion, followed by centrifugation at 600 g for 5 minutes at room temperature. The fatty layer and saline supernatant from the tube were poured out gently in one smooth motion or removed using vacuum suction. The cell pellet thus obtained was resuspended in 40 ml saline and then centrifuged again at 600 g for 5 minutes at room temperature.
After being resuspended again in 5 ml saline, the cell suspension was filtered through a 100-mm filter into a 50-ml conical tube to which 2 ml of saline was added to rinse the remaining cells through the filter. The flow-through was pipetted into a new 50-ml conical tube through a 40-mm filter. The tubes were centrifuged for a third time at 600 g for 5 minutes at room temperature. The cells were resuspended in saline. An aliquot of cell suspension was then removed for cell culture in Dulbecco's modified Eagle's medium/low-glucose medium containing 10% fetal bovine serum for 14 days. Approximately 2.0-3.0 3 10 6 ADMSCs were obtained from each rat. Flow cytometric analysis was performed to identify cellular characteristics after cell labeling with appropriate antibodies on day 14 before transfusion.
Histopathology Scoring of Kidney Injury at Day 5 After the SS Induction
Histopathology scoring was determined in a blinded fashion, as we previously reported [26, 27] . Briefly, the kidney specimens from all animals were fixed in 10% buffered formalin, embedded in paraffin, sectioned at 5 mm, and stained with hematoxylin and eosin (H&E) for light microscopy. The scoring system reflecting the grading of tubular necrosis, loss of brush border, cast formation, and tubular dilatation in 10 randomly chosen, nonoverlapping fields (2003) for each animal was as follows: 0 (none), 1 ( # 10%), 2 (11%-25%), 3 (26%-45%), 4 (46%-75%), and 5 ( $ 76%).
Immunohistochemical and Immunofluorescent Studies
The procedures and protocols for immunohistochemical (IHC) and immunofluorescent (IF) examinations were also based on our recent studies [23, 26, 28] . Briefly, for IHC staining, rehydrated paraffin sections were first treated with 3% H 2 O 2 for 30 minutes and incubated with Immuno-Block reagent (Bio SB Inc., Goleta, CA, http://www.biosb.com) for 30 minutes at room temperature. Sections were then incubated with primary antibodies specifically against CD14 (1:300, Bio SB Inc.) at 4°C overnight. Irrelevant antibody (p53 [1:500; Abcam, Cambridge, UK, http://www.abcam. com] and mouse control IgG [Abcam]) served as controls in the current study. IF staining was performed for the examinations of g-H2AX (1:500; Abcam), macrophage migratory inhibitor factor (MIF) (1:200; Abcam), CD68 (1:100; Abcam), and COX-2 (1:100; Abcam) using respective primary antibody; irrelevant antibodies were used as controls. Three sections of kidney specimens were analyzed in each rat. For quantification, three randomly selected HPFs (3200 or 3400 for IHC and IF studies) were analyzed in each section. The mean number per HPF for each animal was then determined by summation of all numbers divided by 9.
An IHC-based scoring system was adopted for semiquantitative analyses of CD14 in the kidney and bladder as a percentage of positive cells in blinded fashion (score of positively stained cell for CD14: 0 = negative staining; 1= ,15%; 2 = 15%-25%; 3 = 25%-50%; 4 = 50%-75%; 5= .75%-100% per HPF).
Western Blot Analysis of Kidney and Urinary Bladder Specimens
Equal amounts (10-30 mg) of protein extracts from the kidneys were loaded and separated by SDS-polyacrylamide gel electrophoresis using 8%-10% acrylamide gradients. After electrophoresis, the separated proteins were transferred electrophoretically to a polyvinylidene difluoride membrane (Amersham Biosciences, GE Healthcare Life Sciences, Pittsburgh, PA, http://www. gelifesciences.com). Nonspecific proteins were blocked by incubating the membrane in blocking buffer (5% nonfat dry milk in Tris-buffered saline and Tween 20 containing 0.05% Tween 20) overnight. The membranes were incubated with monoclonal antibodies against polyclonal antibodies against tumor necrotic factor (TNF)-a (1:1,000; Cell Signaling Technology, Danvers, MA, http://www.cellsignal.com/); nuclear factor (NF)-kB (1:250; Abcam); matrix metalloproteinase (MMP)-9 (1:3,000; Abcam); interleukin (IL)-1b (1:500; Abcam); RANTES (regulated on activation, normal T cell expressed and secreted) (1:1,000; Cell Signaling Technology); mitochondrial Bax (1:1,000; Abcam); caspases 1, 2, and 3 (1:1,000; Cell Signaling Technology); poly(ADP-ribose) polymerase (PARP) (1: 1,000; Cell Signaling Technology); p21 protein (Cdc42/Rac)-activated kinase 2 (PAK2) (1:1,000; Abcam), NOX-1 (NADPH oxidase 1) (1:1,500; Sigma-Aldrich, St. Louis, MO, http://www. sigmaaldrich.com), and NOX-2 (NADPH oxidase 2) (1:750; Sigma-Aldrich). Signals were detected with horseradish peroxidase-conjugated goat anti-mouse, goat anti-rat, or goat anti-rabbit IgG.
We used the Oxyblot Oxidized Protein Detection Kit (S7150; Chemicon, EMD Millipore, Darmstadt, Germany, https://www. emdmillipore.com) The procedure of 2,4-dinitrophenylhydrazine (DNPH) derivatization was carried out on 6 mg of protein for 15 minutes according to manufacturer's instructions. Onedimensional electrophoresis was carried out on 12% SDS/ polyacrylamide gel after DNPH derivatization. Proteins were transferred to nitrocellulose membranes, which were then incubated in the primary antibody solution (anti-DNP, 1:150) for 2 hours, followed by incubation with the secondary antibody solution (1:300) for 1 hour at room temperature. The washing procedure was repeated 8 times within 40 minutes Immunoreactive bands were visualized by enhanced chemiluminescence (ECL; Amersham Biosciences, GE Healthcare Life Sciences), which was then exposed to Biomax L film (Kodak, Rochester, NY, http://www.kodak.com). For quantification, ECL signals were digitized by using Labworks software (UVP, Upland, CA, http://www.uvp.com). For Oxyblot protein analysis, a standard control was loaded on each gel.
Statistical Analysis
Quantitative data are expressed as mean 6 SD. Statistical analysis was performed by analysis of variance, followed by Bonferroni multiple-comparison post hoc test. All analyses were conducted by using SAS statistical software for Windows, version 8.2 (SAS Institute, Cary, NC, https://www.sas.com/). A p value ,.05 was considered to indicate a statistically significant difference. By day 14 after cell culturing, the flow cytometric analysis (Fig.  1A-1E) showed that the CD90+ and CD29+ surface markers of ADMSCs were the two highest ADMSC population (Fig. 1G) . The spindle-shape picture, a typical appearance of ADMSC, was present in the culture plate (Fig. 1F) .
By day 5, the mortality rate for sepsis syndrome was highest in group 2 and lowest in group 1 and significantly higher in groups 3 and 4 than those in group 5, but there was no difference between groups 3 and 4 (Fig. 1H) .
By day 5 after SS induction, the circulating level of creatinine, an indicator of renal function, showed an identical pattern as mortality rate among the five groups (0.25 6 0.02 vs. 0.57 6 0.03 vs. 0.41 6 0.02 vs. 0.41 6 0.06 vs. 0.33 6 0.02 mg/ml, p , .001) (Fig.  1I ). Combined treatment with ciprofloxacin and ADMSC significantly reduced sepsis syndrome-associated mortality and kidney injury compared with treatment with either one.
Protein Expressions of Inflammatory Biomarkers in Kidneys and Urinary Bladder
The protein expressions of TNF-1a, NF-kB, MMP-9, RANTES, and IL-1b (five proinflammation markers in the kidney and urinary bladder) were lowest in group 1, highest in group 2, significantly higher in group 3 and group 4 than in group 5, and significantly higher in group 4 than in group 3 (Fig. 2) .
IHC and IF Staining for Identification of Inflammatory Cells in Kidneys and Urinary Bladder by Day 5 After Sepsis Induction
IHC findings demonstrated that the cellular expressions of CD14, one indicator of inflammation in the kidneys and urinary bladder, was highest in group 2 and lowest in group 1, significantly higher in groups 3 and 4 than that in group 5, and significantly higher in group 4 than in group 3 (Fig. 3) . Moreover, IF microscopy revealed that the cellular expressions of MIF and CD68 (two other inflammatory cell biomarkers) in the two organs showed an identical pattern compared with that of IHC staining among the five groups (Figs. 4, 5) . 
Protein Expressions of Apoptotic and Oxidative Stress Biomarkers in Kidneys and Urinary Bladder by Day 5 After Sepsis Syndrome Induction
The protein expressions of mitochondrial Bax cleaved caspases 1, 2, and 3; and PARP and PAK2 (six indicators of apoptosis) were highest in group 2 and lowest in group 1, significantly higher in groups 3 and 4 than in group 5, and significantly higher in group 4 than in group 3 in kidneys; there was no significant difference between groups 3 and 4 in the bladder (Fig. 6) . Furthermore, the protein expression of NOX-1 and NOX-2, two indicators of reactive oxygen species, displayed an identical pattern compared with that of apoptosis among the five groups.
Pathological Assessment of the Kidney Parenchyma and Oxidized Protein Expression in Kidney and Bladder by Day 5 After Sepsis Syndrome Induction
The oxidized protein expression, an indicator of oxidative stress, was highest in group 2 and lowest in group 1, significantly higher in groups 3 and 4 than in group 5, and significantly higher in group 4 than in group 3 (Fig. 7) . Additionally, H&E staining of kidney sections revealed that kidney injury score exhibited an identical pattern as oxidative index among the five groups.
IF for Identifying DNA Damaged and Inflammatory Markers of the Kidney Parenchyma at Day 5 After Sepsis Syndrome Procedure
The IF microscopic findings showed that the number of g-H2AX+ cells, a DNA-damaged marker, and the number of COX-2+ cells, an indicator of inflammation, displayed an identical pattern as kidney injury score among the five groups (supplemental online Fig. 1 ).
DISCUSSION
This study, which investigated the therapeutic effect of ADMSCciprofloxacin on SS-induced organ injury, yielded several striking implications. First, the mortality rate was notably increased in animals without treatment, suggesting that the SS animal model was successfully created. Second, both ADMSC and ciprofloxacin were equally effective for protecting against SS-induced urogenital organ damage. Third, combined therapy with ADMSCciprofloxacin was superior to either alone in reducing urogenital organ damage, inflammation, and mortality. The results of this study highlight the potential use of this combined regimen in patients with severe sepsis who responded poorly to conventional medical treatment. Despite the state-of-the-art treatment strategy with advanced pharmacological regimens and in-depth understanding of the underlying mechanism, abundant data have shown that severe SS results in multiple organ failure and a high rate of mortality, especially in elderly patients with comorbidities [1] [2] [3] [4] [5] [6] [7] . Consistently, the most important finding in the present study is that pelvic injection of mixed bacteria not only involved urogenital organ damage but also caused remarkably higher mortality in SS animals without treatment. In this way, our findings corroborated those of previous clinical observational studies [1] [2] [3] [4] [5] [6] [7] . It is not surprising that, compared with SS-only animals, ciprofloxacin therapy remarkably reduced the mortality and urogenital organ damage in animals after SS induction. Of importance is that ADMSC therapy helped suppress mortality and urogenital organ damage, similar to the effect of ciprofloxacin in this experimental setting. Intriguingly, our previous studies [25, 26] have also demonstrated that ADMSC treatment significantly reduced major organ damage and mortality in rats with CLP-induced SS. Therefore, the results of the present study reinforced the findings of our previous studies [25, 26] . One distinctively important finding in the present study is that combined therapy with ciprofloxacin and ADMSC was superior to either one alone in reducing the mortality and urogenital organ damage in the setting of SS. Accordingly, our findings, in addition to strengthening those of our previous studies [25, 26] , also highlight that the combined regimen may be of clinical therapeutic potential for treating highrisk patients with severe SS and poor response to conventional antibiotic therapy.
The underlying mechanisms of SS have been extensively investigated. The high in-hospital mortality caused by the overwhelming infection is mainly attributable to the inappropriate hyperactive immune response (i.e., host response), oxidative stress through overproduction of ROS, and overcompensatory inflammatory reaction [4, 8, 9] , which, in turn, contribute to the direct or indirect assaults on the vital organs [11] [12] [13] [14] . An essential finding in the present study is that the protein and cellular expressions of inflammatory biomarkers were substantially increased in SS animals. Additionally, the generation of ROS and the resulting oxidative stress were strongly upregulated in animals after sepsis induction. Therefore, our findings corroborated those of previous studies [4, 8, 9, [11] [12] [13] [14] . Another interesting finding in the present study is that ADMSC or ciprofloxacin therapy significantly reduced the inflammatory responses, the generation of ROS, and oxidative stress. In particular, combined therapy with ADMSC and ciprofloxacin offered significant benefit in reducing the expressions of these parameters. These findings may explain the superiority of the combined regimen to monotherapy in attenuating urogenital organ damage and mortality.
We propose that the role of ADMSC therapy in reducing the untoward outcomes of SS could be due to multiple mechanisms. Intriguingly, our recent experimental study [29] showed that ADMSC therapy on protecting the organ from ischemiareperfusion injury was not only through suppressing the inflammatory and immune responses but also through an increase in paracrine effects (i.e., upregulating the secretions of antiinflammatory chemokines, such as IL-4, IL-10, and prostaglandin E2). The recent study [29] , therefore, supports our proposal and the results of the current study.
An association between inflammatory reaction, oxidative stress, and cellular apoptosis was previously identified [25] [26] [27] . Clinically, the link between cellular apoptosis and unfavorable outcome has also been clearly delineated [30] . A principal finding in the present study is that the protein (in kidneys and urinary bladder) expressions of proapoptosis markers were significantly increased in animals after induction of sepsis compared with those in sham controls. The degree of apoptosis was significantly reduced after ADMSC or ciprofloxacin treatment and more significantly reduced in the combined treatment group. Our findings could, at least in part, explain the most notable suppression of urogenital organ damage and mortality in animals with sepsis after receiving the combined regimen.
This study has limitations. First, we did not test the optimal dosage of ADMSC for the treatment of SS. Second, we remain uncertain about whether combined treatment with ADMSC and ciprofloxacin offered synergic or merely additional therapeutic benefit in the setting of SS. Third, although abundant data support the effect of combined therapy on improving outcome in rat with SS, this study did not identify the exact underlying mechanisms of this therapy. The proposed mechanisms underlying the observed protection of ADMSC + ciprofloxacin , although the circulating level of creatinine was measured, the urine level of creatinine, albumin, and total protein were not measured in the present study. Accordingly, we did not provide the data on the ratio of urine protein to urine creatine, an indicator of kidney function. Finally, the study period was relative shorter (i.e., only 5 days from SS induction to euthanasia of the animals); therefore, we did not provide relevant information regarding the long-term outcome as well as kidney function, which would have further strengthened the importance of our study.
CONCLUSION
Combined therapy with ADMSC and ciprofloxacin was superior to either therapy alone in improving the outcome in a rodent sepsis model.
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